Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 72603-399

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 72603-399). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Mpd Er 72 mg Figure 1)

A line graph comparing mean plasma methylphenidate concentration (ng/ml) over time (hours) for two dosing regimens: methylphenidate hydrochloride extended-release tablets taken once daily at 18 mg, and methylphenidate 5 mg taken three times daily. The graph shows concentration peaking around 4-8 hours and declining towards 32 hours.*

FDA Label Image

Fig2 (Mpd Er 72 mg Figure 2)

A bar chart comparing the maximum symptoms on the Inattention/Overactivity Scale for Methylphenidate Hydrochloride extended-release tablets once daily versus placebo across three studies. The vertical axis represents symptom severity from no symptoms to maximum symptoms. Each study shows lower symptom scores for Methylphenidate Hydrochloride compared to placebo.*

FDA Label Image

Fig3 (Mpd Er 72 mg Figure 3)

A line graph comparing attention levels over 12 hours post initial dose between methylphenidate hydrochloride extended-release tablets once daily and placebo. The y-axis represents a combined attention subscale from more attentive at the bottom to less attentive at the top, while the x-axis shows hours post initial dose. Two lines depict performance, with methylphenidate generally showing better attention than placebo across time points.*

FDA Label Image

Structure (Methylphenidate 01)

Chemical structure of methylphenidate hydrochloride depicted with a piperidine ring, phenyl group, ester functionality, and hydrochloride (HCl). This structural diagram represents the active ingredient methylphenidate hydrochloride.*

FDA Label Image

Mpd-er-72mg (Methylphenidate Spl Label)

Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP 72 mg by Northstar Rx LLC. The label indicates it is an oral extended-release tablet with a package size of 30 tablets. It includes a barcode, storage instructions (20 to 25°C), and directions to consult the Medication Guide for dosing. The label also lists the product NDC as 72603-399-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.